Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest GlaxoSmithKline Stories

2013-07-01 08:27:49

Payers are Most Receptive to Reimbursing Premium-Priced Novel Therapies that Offer Clinical Improvements in the Rate of Severe Exacerbations, According to a New Report from Decision Resources BURLINGTON, Mass., July 1, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed pulmonologists in the United States and Europe agree that a drug's effect on reducing the exacerbation rate is...

2013-06-28 23:19:03

GranuFlo lawsuit involving patients who allegedly suffered heart attacks, cardiac arrest, stroke or sudden cardiac death while undergoing dialysis treatment with recalled NaturaLyte or GranuFlo dialysis drug, both Fresenius products, grows. Dallas, TX (PRWEB) June 28, 2013 A MDL Statistics Report issued on May 14th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) claims that at least 161 Fresenius GranuFlo lawsuit cases have been filed in federal litigation in the district of...

2013-06-27 12:28:26

DALLAS, June 27, 2013 /PRNewswire/ -- The X-Change Corporation (NASDAQ OTC: XCHC), a U.S. Company specializing in natural cannabinoid-based food and cosmetic products, is proud to announce the appointment of GlaxoSmithKline's former executive Dr. Dorothy Bray, Ph.D., as the new President of the Company. Dr. Bray's extensive experience in the field of drug development, including specific expertise in plant-based research in medicine and nutrition, will help The X-Change Corporation to...

2013-06-26 12:32:17

- PULSE Volunteer Partnership helps build healthy communities by sharing corporate expertise and skills with nonprofits such as Save the Children PHILADELPHIA, June 26, 2013 /PRNewswire/ -- One hundred GlaxoSmithKline (GSK) employees are now beginning long-term assignments (up to six months) with 46 nonprofit and non-governmental organizations in 35 countries. These volunteers will bring needed expertise to organizations working to address serious health challenges through GSK's...

2013-06-26 12:32:03

GSK Survey Shows Americans Don't Know The Truth About Dry Mouth PITTSBURGH, June 26, 2013 /PRNewswire/ -- While prescription drug use is on the rise, medication side effects are discouraging Americans from following their prescribed treatment plans. Many are not aware they can treat symptoms of some common side effects with over-the-counter healthcare products, according to a new survey of 1,040 Americans by Wakefield Research for Biotene, the leading dry mouth symptom treatment....

2013-06-20 23:23:01

A new study published online on June 12, in the Australian and New Zealand Journal of Psychiatry, reveals that paroxetine (Paxil) is linked to birth defects and it should be avoided in the first trimester of pregnancy. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Paxil side effects. San Diego, CA (PRWEB) June 20, 2013 AttorneyOne.com, a...

2013-06-19 14:32:04

Controversial deals that delay generic versions of drugs coming onto the market can lead to consumers paying significantly more for some treatments, according to new research by an academic from the University of East Anglia. Dr Farasat Bokhari´s study shows that moves to investigate and ban pay-to-delay deals — which typically involve a branded manufacturer holding a drug patent paying a rival generic firm to delay the release of its cheaper version — are justified. The...

2013-06-14 12:27:33

CHICAGO, June 14, 2013 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BUD, GSK, COF, SWY, and ONXX. (Photo: http://photos.prnewswire.com/prnh/20120712/CG39046) To see what our analysts have discovered about these stocks read the InvestorsObserver's PriceWatch Alerts at http://www.investorsobserver.com/pr/61320130 (Note: You may have to copy this link into your browser then press the [ENTER] key.) Today's PriceWatch Alerts cover the following stocks: Anheuser-Busch...

2013-06-11 08:33:35

DUBLIN, June 11, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hrlbkd/top_five_global) has announced the addition of the "Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis" [http://www.researchandmarkets.com/research/hrlbkd/top_five_global ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The fragmented market has observed some changes in the...

2013-06-10 08:30:43

SAN DIEGO, June 10, 2013 /PRNewswire/ -- Organovo Holdings, Inc. (OTCQX: ONVO), a biotechnology company focused on delivering breakthrough three-dimensional (3D) bioprinting technology, today announced that Tamar D. Howson has been appointed to the Company's Board of Directors. Ms. Howson was appointed to each of the Board's standing committees, including its audit committee. Ms. Howson is a seasoned business development executive within the pharmaceutical industry, having formerly served...